This invention is directed towards novel alkylamide derivatives as bradykinin
receptor antagonists useful for the treatment of bradykinin modulated disorders
such as pain, inflammation, asthma and allergy. Furthermore, the present invention
is directed to novel alkylamide derivatives as bradykinin receptor agonists useful
for the treatment of bradykinin modulated disorders such as hypertension and the like.